Aurinia Pharmaceuticals Inc
AUPHBiotechnology
$17.21−0.86%As of Oct 29vs prior close
- Market cap
- $2.3B
- P/E (TTM)
- 7.3×
- From 52W high
- −7.57%
- EPS (LTM)
- $2.29
- Revenue (LTM)
- $321.7M
- Net margin
- 100.84%
- Dividend yield
- 0.00%
Nomior Score
77
Fortified DefenderTop 4% of the scored universe
Growth61
Quality83
Value—
Momentum71
Resilience67
Growth
+150.06%revenue a year over 7 fiscal years
FY18 $463KLTM $321.7M
Connections
Revenue to profitQ3 FY26
38% of revenue became net profit, down 5 pts on a year.
Who owns it
1fund